# The Effects of Expectation and Knowledge on Rizatriptan and Placebo Treatment of Acute Migraine Headache

> **NCT00719134** · PHASE4 · COMPLETED · sponsor: **Beth Israel Deaconess Medical Center** · enrollment: 76 (actual)

## Conditions studied

- Episodic Migraine

## Interventions

- **DRUG:** Maxalt
- **DRUG:** placebo pill
- **DRUG:** placebo pills

## Key facts

- **NCT ID:** NCT00719134
- **Lead sponsor:** Beth Israel Deaconess Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2015-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00719134

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00719134, "The Effects of Expectation and Knowledge on Rizatriptan and Placebo Treatment of Acute Migraine Headache". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00719134. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
